The aim of this study is to examine the long-term outcomes after curatively intended resection of duodenal adenocarcinoma.
Study Type
OBSERVATIONAL
Enrollment
113
Adjuvant therapy was generally offered to patients with T4 or lymph node positive disease. As no national Danish guidelines exist, patients were treated based on the oncologists' preference.
Kristian Schaumburg Kiim
Copenhagen NV, Copenhagen, Denmark
3-year survival
Cumulative survival after three years
Time frame: Three years
Duodenal cancer recurrence
Recurrence found by computed tomography scan
Time frame: 5 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.